Short Interest in Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) Grows By 300.0%

Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) was the target of a large increase in short interest during the month of February. As of February 28th, there was short interest totalling 3,600 shares, an increase of 300.0% from the February 13th total of 900 shares. Based on an average trading volume of 0 shares, the short-interest ratio is currently ∞ days.

Santhera Pharmaceuticals Price Performance

Shares of SPHDF stock opened at $16.00 on Friday. Santhera Pharmaceuticals has a twelve month low of $16.00 and a twelve month high of $16.00. The stock’s 50 day simple moving average is $9.95 and its 200 day simple moving average is $10.73.

Santhera Pharmaceuticals Company Profile

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes Vamorolone, which is being developed for the treatments of Duchenne muscular dystrophy (DMD).